B W Walsh

Summary

Affiliation: Harvard University
Country: USA

Publications

  1. ncbi request reprint Effects of raloxifene on serum lipids and coagulation factors in healthy postmenopausal women
    B W Walsh
    Brigham and Women s Hospital, Boston, Mass 02115, USA
    JAMA 279:1445-51. 1998
  2. ncbi request reprint Relationship between serum estradiol levels and the increases in high-density lipoprotein levels in postmenopausal women treated with oral estradiol
    B W Walsh
    Department of Obstetrics and Gynecology, Brigham and Women s Hospital, Boston, Massachusetts 02115, USA
    J Clin Endocrinol Metab 84:985-9. 1999
  3. ncbi request reprint The effects of hormone replacement therapy and raloxifene on C-reactive protein and homocysteine in healthy postmenopausal women: a randomized, controlled trial
    B W Walsh
    Brigham and Women s Hospital, Boston, Massachusetts 02115, USA
    J Clin Endocrinol Metab 85:214-8. 2000
  4. ncbi request reprint The effects of estrogen and selective estrogen receptor modulators on cardiovascular risk factors
    B W Walsh
    Department of Obstetrics and Gynecology, Brigham and Women s Hospital, Boston, Massachusetts 02115, USA
    Ann N Y Acad Sci 949:163-7. 2001
  5. ncbi request reprint Effect of estrogen on very low density lipoprotein and low density lipoprotein subclass metabolism in postmenopausal women
    H Campos
    Department of Nutrition, Harvard School of Public Health, Boston, Massachusetts 02115, USA
    J Clin Endocrinol Metab 82:3955-63. 1997
  6. ncbi request reprint Estradiol with or without progesterone and ambulatory blood pressure in postmenopausal women
    E W Seely
    Department of Medicine, Cardiovascular Division, Brigham and Women s Hospital, Boston, Massachusetts, USA
    Hypertension 33:1190-4. 1999
  7. ncbi request reprint Differential metabolism of human VLDL according to content of ApoE and ApoC-III
    K Tomiyasu
    Department of Nutrition, Harvard School of Public Health, Boston, Massachusetts, USA
    Arterioscler Thromb Vasc Biol 21:1494-500. 2001

Collaborators

Detail Information

Publications7

  1. ncbi request reprint Effects of raloxifene on serum lipids and coagulation factors in healthy postmenopausal women
    B W Walsh
    Brigham and Women s Hospital, Boston, Mass 02115, USA
    JAMA 279:1445-51. 1998
    ..Raloxifene is a selective estrogen receptor modulator that has estrogen-agonistic effects on bone and estrogen-antagonistic effects on breast and uterus...
  2. ncbi request reprint Relationship between serum estradiol levels and the increases in high-density lipoprotein levels in postmenopausal women treated with oral estradiol
    B W Walsh
    Department of Obstetrics and Gynecology, Brigham and Women s Hospital, Boston, Massachusetts 02115, USA
    J Clin Endocrinol Metab 84:985-9. 1999
    ..Thus, measurement of an E2 level the morning after taking 1 mg estradiol at bedtime identifies who may benefit from improvement in HDL levels by increasing to a 2-mg dose...
  3. ncbi request reprint The effects of hormone replacement therapy and raloxifene on C-reactive protein and homocysteine in healthy postmenopausal women: a randomized, controlled trial
    B W Walsh
    Brigham and Women s Hospital, Boston, Massachusetts 02115, USA
    J Clin Endocrinol Metab 85:214-8. 2000
    ....
  4. ncbi request reprint The effects of estrogen and selective estrogen receptor modulators on cardiovascular risk factors
    B W Walsh
    Department of Obstetrics and Gynecology, Brigham and Women s Hospital, Boston, Massachusetts 02115, USA
    Ann N Y Acad Sci 949:163-7. 2001
    ..The net effect of these differences is unclear. Proof that raloxifene or HRT reduces the risk of heart disease must await the results of ongoing clinical trials with cardiovascular event end points...
  5. ncbi request reprint Effect of estrogen on very low density lipoprotein and low density lipoprotein subclass metabolism in postmenopausal women
    H Campos
    Department of Nutrition, Harvard School of Public Health, Boston, Massachusetts 02115, USA
    J Clin Endocrinol Metab 82:3955-63. 1997
    ..The reduced plasma residence times of light and dense LDL both may be antiatherogenic, even though, for dense LDL, the concentration did not change...
  6. ncbi request reprint Estradiol with or without progesterone and ambulatory blood pressure in postmenopausal women
    E W Seely
    Department of Medicine, Cardiovascular Division, Brigham and Women s Hospital, Boston, Massachusetts, USA
    Hypertension 33:1190-4. 1999
    ..This BP-lowering effect may be responsible for the lower incidence of hypertension in premenopausal than in postmenopausal women...
  7. ncbi request reprint Differential metabolism of human VLDL according to content of ApoE and ApoC-III
    K Tomiyasu
    Department of Nutrition, Harvard School of Public Health, Boston, Massachusetts, USA
    Arterioscler Thromb Vasc Biol 21:1494-500. 2001
    ..In conclusion, metabolism of human VLDL particles is influenced by their content of apoE, further modulated by the coexistence of apoC-III...